WASHINGTON — President Biden’s “moonshot” biomedical research agency will be housed within the National Institutes of Health, according to two sources familiar with the decision-making process.
The decision marks the end of a lengthy debate in Washington about whether the new agency, known as ARPA-H, should be independent or exist as a wing of the NIH.
But there’s a twist: Instead of reporting to the NIH director, the new agency’s leader will report directly to the secretary of health and human services.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
